Treatment of MRSA Infections in an African-American Male with G6PD Deficiency

Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency affecting erythrocytes is the most common enzymopathy in humans. It requires caution with the intake of oxidizing substances (e.g., medications and foods) because of the threat of hemolysis. Less recognized is the threat of a deficiency in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of emergency medicine 2009-10, Vol.37 (3), p.273-278
Hauptverfasser: Paek, David S., MD, Nadkarni, Milan, MD, Singla, Manav, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 278
container_issue 3
container_start_page 273
container_title The Journal of emergency medicine
container_volume 37
creator Paek, David S., MD
Nadkarni, Milan, MD
Singla, Manav, MD
description Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency affecting erythrocytes is the most common enzymopathy in humans. It requires caution with the intake of oxidizing substances (e.g., medications and foods) because of the threat of hemolysis. Less recognized is the threat of a deficiency in G6PD that alters neutrophil function, which can compromise the killing of microbes by the oxidative burst mechanism. This results from a secondary alteration in the NADPH oxidase pathway. Methicillin-resistant Staphylococcus aureus (MRSA) infection, which is usually observed after exposure in the hospital setting, is becoming increasingly common in a community setting. Here we show the risk of MRSA and G6PD deficiency and discuss the pitfalls of G6PD deficiency.
doi_str_mv 10.1016/j.jemermed.2007.10.049
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734058790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0736467907009043</els_id><sourcerecordid>734058790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-e2ee4132fc23da823a9b9e70249737d5b2250624145af133eb4d920dfb71f3df3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhL1Q-wSnL-CNxckGsWloqdQWi5Ww5zlg4JE6xs0X77-uwCwcOcLI1fmZe-RlCzhisGbDqbb_uccQ4YrfmACoX1yCbJ2TFRcmLEnjzlKxAiaqQlWpOyIuUegCmoGbPyQmrZQkS1Ips7yKaecQw08nR7ZfbDb0ODu3sp5CoD9QEunHRWxOKTQ5cLnRrBqQ__fyNXlWfL-gFOm89Brt_SZ45MyR8dTxPydfLD3fnH4ubT1fX55ubwspSzAVyRMkEd5aLztRcmKZtUAGXjRKqK1vOS6i4ZLI0jgmBrewaDp1rFXOic-KUvDnMvY_Tjx2mWY8-WRwGE3DaJa2EhLJWDWTy9T9JzqBWChawOoA2TilFdPo--tHEvWagF-W617-V60X5Us_Kc-PZMWHXLm9_2o6OM_D-AGA28uAx6vTLFnY-ZtG6m_z_M979NcIOPuRdDN9xj6mfdjFk35rpxDXo22Xxy94h_6wBKcQj0C-oIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21087700</pqid></control><display><type>article</type><title>Treatment of MRSA Infections in an African-American Male with G6PD Deficiency</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Paek, David S., MD ; Nadkarni, Milan, MD ; Singla, Manav, MD</creator><creatorcontrib>Paek, David S., MD ; Nadkarni, Milan, MD ; Singla, Manav, MD</creatorcontrib><description>Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency affecting erythrocytes is the most common enzymopathy in humans. It requires caution with the intake of oxidizing substances (e.g., medications and foods) because of the threat of hemolysis. Less recognized is the threat of a deficiency in G6PD that alters neutrophil function, which can compromise the killing of microbes by the oxidative burst mechanism. This results from a secondary alteration in the NADPH oxidase pathway. Methicillin-resistant Staphylococcus aureus (MRSA) infection, which is usually observed after exposure in the hospital setting, is becoming increasingly common in a community setting. Here we show the risk of MRSA and G6PD deficiency and discuss the pitfalls of G6PD deficiency.</description><identifier>ISSN: 0736-4679</identifier><identifier>EISSN: 2352-5029</identifier><identifier>DOI: 10.1016/j.jemermed.2007.10.049</identifier><identifier>PMID: 18450407</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>African Americans ; Anti-Bacterial Agents - therapeutic use ; Child, Preschool ; chronic granulomatous disease (CGD) ; Clindamycin - therapeutic use ; Emergency ; Emergency Service, Hospital ; glucose-6-phosphate dehydrogenase (G6PD) ; Glucosephosphate Dehydrogenase Deficiency - complications ; Glucosephosphate Dehydrogenase Deficiency - diagnosis ; Humans ; Infant ; Male ; methicillin-resistant Staphylococcus aureus (MRSA) ; Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification ; Recurrence ; Soft Tissue Infections - complications ; Soft Tissue Infections - drug therapy ; Soft Tissue Infections - ethnology ; Staphylococcal Infections - complications ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - ethnology ; Staphylococcus aureus</subject><ispartof>The Journal of emergency medicine, 2009-10, Vol.37 (3), p.273-278</ispartof><rights>Elsevier Inc.</rights><rights>2009 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-e2ee4132fc23da823a9b9e70249737d5b2250624145af133eb4d920dfb71f3df3</citedby><cites>FETCH-LOGICAL-c453t-e2ee4132fc23da823a9b9e70249737d5b2250624145af133eb4d920dfb71f3df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jemermed.2007.10.049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18450407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paek, David S., MD</creatorcontrib><creatorcontrib>Nadkarni, Milan, MD</creatorcontrib><creatorcontrib>Singla, Manav, MD</creatorcontrib><title>Treatment of MRSA Infections in an African-American Male with G6PD Deficiency</title><title>The Journal of emergency medicine</title><addtitle>J Emerg Med</addtitle><description>Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency affecting erythrocytes is the most common enzymopathy in humans. It requires caution with the intake of oxidizing substances (e.g., medications and foods) because of the threat of hemolysis. Less recognized is the threat of a deficiency in G6PD that alters neutrophil function, which can compromise the killing of microbes by the oxidative burst mechanism. This results from a secondary alteration in the NADPH oxidase pathway. Methicillin-resistant Staphylococcus aureus (MRSA) infection, which is usually observed after exposure in the hospital setting, is becoming increasingly common in a community setting. Here we show the risk of MRSA and G6PD deficiency and discuss the pitfalls of G6PD deficiency.</description><subject>African Americans</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Child, Preschool</subject><subject>chronic granulomatous disease (CGD)</subject><subject>Clindamycin - therapeutic use</subject><subject>Emergency</subject><subject>Emergency Service, Hospital</subject><subject>glucose-6-phosphate dehydrogenase (G6PD)</subject><subject>Glucosephosphate Dehydrogenase Deficiency - complications</subject><subject>Glucosephosphate Dehydrogenase Deficiency - diagnosis</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>methicillin-resistant Staphylococcus aureus (MRSA)</subject><subject>Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification</subject><subject>Recurrence</subject><subject>Soft Tissue Infections - complications</subject><subject>Soft Tissue Infections - drug therapy</subject><subject>Soft Tissue Infections - ethnology</subject><subject>Staphylococcal Infections - complications</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - ethnology</subject><subject>Staphylococcus aureus</subject><issn>0736-4679</issn><issn>2352-5029</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhL1Q-wSnL-CNxckGsWloqdQWi5Ww5zlg4JE6xs0X77-uwCwcOcLI1fmZe-RlCzhisGbDqbb_uccQ4YrfmACoX1yCbJ2TFRcmLEnjzlKxAiaqQlWpOyIuUegCmoGbPyQmrZQkS1Ips7yKaecQw08nR7ZfbDb0ODu3sp5CoD9QEunHRWxOKTQ5cLnRrBqQ__fyNXlWfL-gFOm89Brt_SZ45MyR8dTxPydfLD3fnH4ubT1fX55ubwspSzAVyRMkEd5aLztRcmKZtUAGXjRKqK1vOS6i4ZLI0jgmBrewaDp1rFXOic-KUvDnMvY_Tjx2mWY8-WRwGE3DaJa2EhLJWDWTy9T9JzqBWChawOoA2TilFdPo--tHEvWagF-W617-V60X5Us_Kc-PZMWHXLm9_2o6OM_D-AGA28uAx6vTLFnY-ZtG6m_z_M979NcIOPuRdDN9xj6mfdjFk35rpxDXo22Xxy94h_6wBKcQj0C-oIQ</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Paek, David S., MD</creator><creator>Nadkarni, Milan, MD</creator><creator>Singla, Manav, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20091001</creationdate><title>Treatment of MRSA Infections in an African-American Male with G6PD Deficiency</title><author>Paek, David S., MD ; Nadkarni, Milan, MD ; Singla, Manav, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-e2ee4132fc23da823a9b9e70249737d5b2250624145af133eb4d920dfb71f3df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>African Americans</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Child, Preschool</topic><topic>chronic granulomatous disease (CGD)</topic><topic>Clindamycin - therapeutic use</topic><topic>Emergency</topic><topic>Emergency Service, Hospital</topic><topic>glucose-6-phosphate dehydrogenase (G6PD)</topic><topic>Glucosephosphate Dehydrogenase Deficiency - complications</topic><topic>Glucosephosphate Dehydrogenase Deficiency - diagnosis</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>methicillin-resistant Staphylococcus aureus (MRSA)</topic><topic>Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification</topic><topic>Recurrence</topic><topic>Soft Tissue Infections - complications</topic><topic>Soft Tissue Infections - drug therapy</topic><topic>Soft Tissue Infections - ethnology</topic><topic>Staphylococcal Infections - complications</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - ethnology</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paek, David S., MD</creatorcontrib><creatorcontrib>Nadkarni, Milan, MD</creatorcontrib><creatorcontrib>Singla, Manav, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paek, David S., MD</au><au>Nadkarni, Milan, MD</au><au>Singla, Manav, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of MRSA Infections in an African-American Male with G6PD Deficiency</atitle><jtitle>The Journal of emergency medicine</jtitle><addtitle>J Emerg Med</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>37</volume><issue>3</issue><spage>273</spage><epage>278</epage><pages>273-278</pages><issn>0736-4679</issn><eissn>2352-5029</eissn><abstract>Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency affecting erythrocytes is the most common enzymopathy in humans. It requires caution with the intake of oxidizing substances (e.g., medications and foods) because of the threat of hemolysis. Less recognized is the threat of a deficiency in G6PD that alters neutrophil function, which can compromise the killing of microbes by the oxidative burst mechanism. This results from a secondary alteration in the NADPH oxidase pathway. Methicillin-resistant Staphylococcus aureus (MRSA) infection, which is usually observed after exposure in the hospital setting, is becoming increasingly common in a community setting. Here we show the risk of MRSA and G6PD deficiency and discuss the pitfalls of G6PD deficiency.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>18450407</pmid><doi>10.1016/j.jemermed.2007.10.049</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0736-4679
ispartof The Journal of emergency medicine, 2009-10, Vol.37 (3), p.273-278
issn 0736-4679
2352-5029
language eng
recordid cdi_proquest_miscellaneous_734058790
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects African Americans
Anti-Bacterial Agents - therapeutic use
Child, Preschool
chronic granulomatous disease (CGD)
Clindamycin - therapeutic use
Emergency
Emergency Service, Hospital
glucose-6-phosphate dehydrogenase (G6PD)
Glucosephosphate Dehydrogenase Deficiency - complications
Glucosephosphate Dehydrogenase Deficiency - diagnosis
Humans
Infant
Male
methicillin-resistant Staphylococcus aureus (MRSA)
Methicillin-Resistant Staphylococcus aureus - isolation & purification
Recurrence
Soft Tissue Infections - complications
Soft Tissue Infections - drug therapy
Soft Tissue Infections - ethnology
Staphylococcal Infections - complications
Staphylococcal Infections - drug therapy
Staphylococcal Infections - ethnology
Staphylococcus aureus
title Treatment of MRSA Infections in an African-American Male with G6PD Deficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T19%3A03%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20MRSA%20Infections%20in%20an%20African-American%20Male%20with%20G6PD%20Deficiency&rft.jtitle=The%20Journal%20of%20emergency%20medicine&rft.au=Paek,%20David%20S.,%20MD&rft.date=2009-10-01&rft.volume=37&rft.issue=3&rft.spage=273&rft.epage=278&rft.pages=273-278&rft.issn=0736-4679&rft.eissn=2352-5029&rft_id=info:doi/10.1016/j.jemermed.2007.10.049&rft_dat=%3Cproquest_cross%3E734058790%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21087700&rft_id=info:pmid/18450407&rft_els_id=1_s2_0_S0736467907009043&rfr_iscdi=true